http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464567-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5160388b652e0db4292b7cef4b317ba6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79fb524eb72f4d87da67e229dd56d2c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d1164587467f7af3a02236241f6afef
publicationDate 2012-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2464567-C1
titleOfInvention Method and kit for quantitative immunoassay of human complement c1 inhibitor
abstract FIELD: medicine. n SUBSTANCE: method under the invention provides that the preparation pyrogenal is sorbed in microplate wells for the purpose of immunoassay; then the microplate wells are added with a solution of an analysed samples containing complement human C1 complement inhibitor with the unknown concentration. Then the plates are incubated, and after washing and drying, a conjugate of enzyme with C1 inhibitor antibodies and a substratum of this enzyme are added into the wells. The amount of the prepared enzymatic reaction product enables calculating the content of the C1 inhibitor in the analysed sample. A kit for implementing the method comprises a flat-bottomed microplate with the sorbed preparation of pyrogenal, the conjugate of the enzyme with the human C1 inhibitor antibodies, a substrate buffer of this enzyme and a reference for the C1 inhibitor. n EFFECT: use of the method enables implementing quantitation of the C1 inhibitor using an ability of the latter to bind to lipopolysaccharide. n 2 cl, 1 dwg, 2 ex
priorityDate 2011-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2195662-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MNN7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22734939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A287B5Y6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17454
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI3L5U6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M7Q5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID716
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2TBI0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4BTH8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491441
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID767827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2294
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2QW61
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18428
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449046755
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ61805
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ63313
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1P6E1

Total number of triples: 35.